🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

1 AM Vegetarian Tablet(s) Serving Size
30 Servings
Other Combinations Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calcium
30 mg (3% DV)
Steviosides
375 mg
Proprietary Blend
85 mg

Other Ingredients

Microcrystalline Cellulose Croscarmellose Sodium Stearic Acid Fiber, Soluble Hydroxypropyl Methylcellulose Stearate Silica Glycerin Riboflavin Spirulina Extract

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Vegetarian Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Morning Dose Just push tablet through back of packaging to use!

Directions: Take one (1) AM tablet in the morning and one (1) PM tablet 30-60 minutes before bed, or as recommended by a healthcare practitioner.

⚠️ Warnings & Precautions

Warnings: Keep out of reach of children.

Do not exceed recommended dose. Do not purchase if outer seal is damaged.

Consult with your physician if you are undergoing treatment for a medical condition of if you are pregnant or lactating.

Read entire box and follow directions carefully.

Caution: After taking the PM tablet, do not attempt to drive or operate heavy machinery and use caution if combining with alcohol. To report a serious adverse event or obtain product information, contact 1-866-280-2852.

🧪 Formulation Notes

Twice-daily formula in convenient blister packaging

Advanced support to maintain already healthy blood pressure AM

Gluten free Non GMO LE Certified

Additional Information

Non GMO LE Certified

Store in a cool dry place.

Product Details

DSLD Entry Date 2025-05-21
Product Type Other Combinations
Form Tablet or Pill
Bundle Triple Action Blood Pressure
DSLD ID 328747
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →